• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Rev Cardiovasc Med . Acute right ventricular dysfunction in severe COVID-19 pneumonia

tetano

Editor, Senior Moderator
Rev Cardiovasc Med


. 2020 Dec 30;21(4):635-641.
doi: 10.31083/j.rcm.2020.04.159.
Acute right ventricular dysfunction in severe COVID-19 pneumonia


Yun-Long Li[SUP] 1 [/SUP], Jun-Bo Zheng[SUP] 1 [/SUP], Yu Jin[SUP] 2 [/SUP], Rong Tang[SUP] 1 [/SUP], Ming Li[SUP] 1 [/SUP], Chun-Hong Xiu[SUP] 3 [/SUP], Qing-Qing Dai[SUP] 1 [/SUP], Shu Zuo[SUP] 1 [/SUP], Huai-Quan Wang[SUP] 1 [/SUP], Hong-Liang Wang[SUP] 1 [/SUP], Ming-Yan Zhao[SUP] 4 [/SUP], Ming Ye[SUP] 1 [/SUP], Kai-Jiang Yu[SUP] 4 [/SUP]



Affiliations
Free article

Abstract

To investigate the right heart function in coronavirus disease 2019 (COVID-19) patients with acute respiratory distress syndrome (ARDS), a retrospective analysis of 49 COVID-19 patients with ARDS was performed. Patients were divided into severe group and critically-severe group according to the severity of illness. Age-matched healthy volunteers were recruited as a control group. The cardiac cavity diameters, tricuspid annular plane systolic excursion (TAPSE), tricuspid valve regurgitation pressure gradient biggest (TRPG), pulmonary arterial systolic pressure (PASP), maximum inferior vena cava diameter (IVCmax) and minimum diameter (IVCmin), and inferior vena cava collapse index (ICV-CI) were measured using echocardiography. We found that the TAPSE was significantly decreased in pneumonia patients compared to healthy subjects (P < 0.0001), and it was significantly lower in critically-severe patients (P = 0.0068). The TAPSE was less than 17 mm in three (8.6%) severe and five (35.7%) critically-severe patients. In addition, the TAPSE was significantly decreased in severe ARDS patients than in mild ARDS patients. The IVCmax and IVCmin were significantly increased in critically-severe patients compared to healthy subjects and severe patients (P < 0.01), whereas the ICV-CI was significantly decreased (P < 0.05). COVID-19 patients had significantly larger right atrium and ventricle than healthy controls (P < 0.01). The left ventricular ejection fraction (LVEF) in critically-severe patients was significantly lower than that in severe patients and healthy controls (P < 0.05). Right ventricular function was impaired in critically-severe COVID-19 patients. The assessment and protection of the right heart function in COVID-19 patients should be strengthened.

Keywords: Coronavirus disease 2019; acute respiratory distress syndrome; echocardiography; retrospective study; right ventricular function.
 
Back
Top Bottom